For Immediate Release 31 July 2008
PROTEOME SCIENCES plc
("Proteome Sciences" or the "Company")
PRESS RELEASE
DIRECTORS' SHAREHOLDINGS
Proteome Sciences announces that on 31 July 2008 it granted a conditional award
of 1,882,500 Ordinary Shares of 1p each in the Company ("Ordinary Shares") to
C.D.J. Pearce, Chief Executive and of 1,170,000 Ordinary Shares of 1p each to
J.L. Malthouse, Finance Director, under its Long-Term Incentive Plan ("LTIP")
based on a closing mid-market price on 30 July 2008 of 20p per Ordinary Share.
In accordance with the rules of the LTIP, the Ordinary Shares awarded will vest
3 years after the date of grant subject to the Company achieving a target total
shareholder return (TSR) over a three-year performance period relative to the
AIM Healthcare Index at the start of that period. TSR is the aggregate of share
price growth and the value of dividend payments during the performance period.
No shares will be released unless the Company's TSR performance exceeds that of
the index, in which case 30% of the award will vest with full vesting only if
the Company's TSR performance exceeds that of the Index by 10%, with a pro-rata
award between 30% and 100% for each percentage point of out-performance up to
10%.
The Remuneration Committee of the Board of Directors believes that today's
award under the LTIP aligns the interests of shareholders with those of the
executive by making the award dependent on the success of management in
delivering superior returns to shareholders.
C.D.J. Pearce currently holds 6,538,075 shares in the Company, and has a
previous conditional award under the LTIP of up to 504,523 shares.
J.L. Malthouse currently holds 625,000 shares in the Company, and has a
previous conditional award under the LTIP of up to 470,352 shares.
Ends
Proteome Sciences plc
Christopher Pearce James Malthouse
Chief Executive Officer Finance Director
christopher.pearce@proteomics.com james.malthouse@proteomics.com
Tel: +44 (0)1932 865065
Nominated Adviser
Landsbanki Securities (UK) Limited
Shaun Dobson / Claes Spång Tel: +44 (0)20 7426 9000
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.